Dracen Pharmaceuticals' Series A Round

Dracen Pharmaceuticals raised a round of funding on March 23, 2018. Investors include Deerfield Management.

Dracen Pharmaceuticals is a privately-funded biotech company developing proprietary glutamine antagonists discovered at the Johns Hopkins University and the Institute of Organic Chemistry and Biochemi…

Articles about Dracen Pharmaceuticals' Series A Round: